Original publication: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity
Clin Endocrinol (Oxf)
.
2020 Nov;93(5):629-630.
doi: 10.1111/cen.14310.
Epub 2020 Sep 10.
Authors
Grigorios Panagiotou
1
,
Su Ann Tee
1
,
Yasir Ihsan
1
,
Waseem Athar
2
,
Gabriella Marchitelli
3
,
Donna Kelly
4
,
Christopher S Boot
5
,
Nadia Stock
3
,
James Macfarlane
2
,
Adrian R Martineau
6
,
Graham P Burns
2
,
Richard Quinton
1
7
Affiliations
1
Department of Endocrinology, Diabetes & Metabolism, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
2
Department of Respiratory Medicine, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
3
Department of Acute Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
4
Department of Anaesthetics & Critical Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
5
Department of Blood Sciences, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
6
Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
7
Translational & Clinical Research Institute, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
PMID:
32780518
DOI:
10.1111/cen.14310
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Vitamin D* / analogs & derivatives
Substances
Vitamin D
25-hydroxyvitamin D